Skip to main content
Top
Published in: Current Atherosclerosis Reports 5/2021

01-05-2021 | Mammography | Women and Ischemic Heart Disease (J.M. Peña and F. Lin, Section Editors)

Breast Arterial Calcification: A Potential Biomarker for Atherosclerotic Cardiovascular Disease Risk?

Authors: Yeonyee E. Yoon, Bo La Yun, Kyoung Min Kim, Jung-Won Suh

Published in: Current Atherosclerosis Reports | Issue 5/2021

Login to get access

Abstract

Purpose of Review

We aimed to summarize the current evidence regarding the association between breast arterial calcification (BAC) and atherosclerotic cardiovascular disease (ASCVD) in women and discuss the potential role of BAC in the risk stratification and preventive approaches for ASCVD.

Recent Findings

BAC has emerged as a potential women-specific risk marker for ASCVD. Although BAC presents as a medial calcification of the arteries, notably different from the intimal atherosclerotic process, current evidence supports a correlation between BAC and ASCVD risk factors or subclinical and clinical ASCVD, such as coronary artery disease or stroke. As millions of women undergo mammograms each year, the potential clinical application of BAC in enhanced ASCVD risk estimation, with no additional cost or radiation, has tremendous appeal.

Summary

Although further research regarding optimal risk assessment and management in women with BAC is required, the presence of BAC should prompt healthy cardiovascular lifestyle modifications.
Literature
1.
go back to reference Heron M. Deaths: leading causes for 2017. Natl Vital Stat Rep. 2019;68(6):1–77.PubMed Heron M. Deaths: leading causes for 2017. Natl Vital Stat Rep. 2019;68(6):1–77.PubMed
4.
go back to reference • Brown HL, Warner JJ, Gianos E, Gulati M, Hill AJ, Hollier LM, et al. Promoting risk identification and reduction of cardiovascular disease in women through collaboration with obstetricians and gynecologists: a presidential advisory from the American Heart Association and the American College of Obstetricians and Gynecologists. Circulation. 2018;137(24):e843–e52. https://doi.org/10.1161/cir.0000000000000582This article proposed a set of principles to guide risk stratification and prevention of ASCVD in women.CrossRefPubMed • Brown HL, Warner JJ, Gianos E, Gulati M, Hill AJ, Hollier LM, et al. Promoting risk identification and reduction of cardiovascular disease in women through collaboration with obstetricians and gynecologists: a presidential advisory from the American Heart Association and the American College of Obstetricians and Gynecologists. Circulation. 2018;137(24):e843–e52. https://​doi.​org/​10.​1161/​cir.​0000000000000582​This article proposed a set of principles to guide risk stratification and prevention of ASCVD in women.CrossRefPubMed
14.
go back to reference •• Yoon YE, Kim KM, Han JS, Kang S-H, Chun EJ, Ahn S, et al. Prediction of subclinical coronary artery disease with breast arterial calcification and low bone mass in asymptomatic women. JACC Cardiovasc Imaging. 2019;12(7):1202–11. https://doi.org/10.1016/j.jcmg.2018.07.004This study suggests that BAC has a strong association with subclinical CAD in asymptomatic women.CrossRefPubMed •• Yoon YE, Kim KM, Han JS, Kang S-H, Chun EJ, Ahn S, et al. Prediction of subclinical coronary artery disease with breast arterial calcification and low bone mass in asymptomatic women. JACC Cardiovasc Imaging. 2019;12(7):1202–11. https://​doi.​org/​10.​1016/​j.​jcmg.​2018.​07.​004This study suggests that BAC has a strong association with subclinical CAD in asymptomatic women.CrossRefPubMed
38.
go back to reference van Noord PA, Beijerinck D, Kemmeren JM, van der Graaf Y. Mammograms may convey more than breast cancer risk: breast arterial calcification and arterio-sclerotic related diseases in women of the DOM cohort. Eur J Cancer Prev. 1996;5(6):483–7.PubMed van Noord PA, Beijerinck D, Kemmeren JM, van der Graaf Y. Mammograms may convey more than breast cancer risk: breast arterial calcification and arterio-sclerotic related diseases in women of the DOM cohort. Eur J Cancer Prev. 1996;5(6):483–7.PubMed
47.
go back to reference Yalçin Şafak K, Eratalay A, Dülger İliş E, Umarusman TN. The relationship of breast arterial calcification detected in mammographic examinations with cardiovascular diseases, cardiovascular risk factors, parity, and breastfeeding. Turk J Med Sci. 2016;46(3):641–5. https://doi.org/10.3906/sag-1502-126.CrossRefPubMed Yalçin Şafak K, Eratalay A, Dülger İliş E, Umarusman TN. The relationship of breast arterial calcification detected in mammographic examinations with cardiovascular diseases, cardiovascular risk factors, parity, and breastfeeding. Turk J Med Sci. 2016;46(3):641–5. https://​doi.​org/​10.​3906/​sag-1502-126.CrossRefPubMed
50.
go back to reference Abi Rafeh N, Castellanos MR, Khoueiry G, Meghani M, El-Sayegh S, Wetz RV, et al. Association between coronary artery disease diagnosed by coronary angiography and breast arterial calcifications on mammography: meta-analysis of the data. J Womens Health (Larchmt). 2012;21(10):1053–8. https://doi.org/10.1089/jwh.2011.3388.CrossRef Abi Rafeh N, Castellanos MR, Khoueiry G, Meghani M, El-Sayegh S, Wetz RV, et al. Association between coronary artery disease diagnosed by coronary angiography and breast arterial calcifications on mammography: meta-analysis of the data. J Womens Health (Larchmt). 2012;21(10):1053–8. https://​doi.​org/​10.​1089/​jwh.​2011.​3388.CrossRef
60.
go back to reference Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018;2019:139(25)–e1143. https://doi.org/10.1161/cir.0000000000000625.CrossRef Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018;2019:139(25)–e1143. https://​doi.​org/​10.​1161/​cir.​0000000000000625​.CrossRef
61.
66.
go back to reference Byrne D, O’Connor L, Jennings S, Bennett K, Murphy AW. A survey of GPs awareness and use of risk assessment tools and cardiovascular disease prevention guidelines. Ir Med J. 2015;108(7):204–7.PubMed Byrne D, O’Connor L, Jennings S, Bennett K, Murphy AW. A survey of GPs awareness and use of risk assessment tools and cardiovascular disease prevention guidelines. Ir Med J. 2015;108(7):204–7.PubMed
Metadata
Title
Breast Arterial Calcification: A Potential Biomarker for Atherosclerotic Cardiovascular Disease Risk?
Authors
Yeonyee E. Yoon
Bo La Yun
Kyoung Min Kim
Jung-Won Suh
Publication date
01-05-2021
Publisher
Springer US
Published in
Current Atherosclerosis Reports / Issue 5/2021
Print ISSN: 1523-3804
Electronic ISSN: 1534-6242
DOI
https://doi.org/10.1007/s11883-021-00924-5

Other articles of this Issue 5/2021

Current Atherosclerosis Reports 5/2021 Go to the issue

Evidence-Based Medicine, Clinical Trials and Their Interpretations (K. Nasir, Section Editor)

Polypills in Cardiovascular Disease Prevention: Mass-Strategy Approach, Precision Medicine, or an Essential Intertwine Between Them?

Evidence-Based Medicine, Clinical Trials and Their Interpretations (K. Nasir, Section Editor)

Strengthening the Learning Health System in Cardiovascular Disease Prevention: Time to Leverage Big Data and Digital Solutions

Nutrition (K. Petersen, Section Editor)

Time-Restricted Eating to Improve Cardiovascular Health

Cardiometabolic Disease and Treatment (E. Brinton, Section Editor)

ANGPTL3 and Apolipoprotein C-III as Novel Lipid-Lowering Targets

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.